AH Equity Partners Bio II, L.L.C. sold $12M of NAUT
owner at Nautilus Biotechnology, Inc.. 5,000,000 shares at an average of $2.35, traded Jun 2, 2026, filed Jun 4, 2026.
Score components
- +12Role10% owner
- +25Trade size$11.8M at market
- +10Share of holdings soldSold 31% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001231919-26-000599, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | SOpen-market sale Common Stockindirect: By AH Bio Fund II, L.P. | -4,615,974 | $2.35 | $11M | 11,682,032 | Jun 4, 2026 |
| Jun 2, 2026 | SOpen-market sale Common Stockindirect: By Andreessen Horowitz LSV Fund II, L.P. | -384,026 | $2.35 | $902k | 971,885 | Jun 4, 2026 |
Related signals
Other insiders at Nautilus Biotechnology, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 28Weak | NAUTbuy Nautilus Biotechnology, Inc. | Sujal M Patel CEO, President, and Secretary | $65k 25,000 shares | +0% | |
| 23Weak | NAUTbuy Nautilus Biotechnology, Inc. | Kentaro Suzuki Chief Marketing Officer | $5,960 4,000 shares | - | |
| 44Moderate | Nautilus Biotechnology, Inc. | Sujal M Patel CEO, President, and Secretary | $136k 200,000 shares | +2% | |
| 29Weak | Nautilus Biotechnology, Inc. | Matthew B. Murphy General Counsel | $13k 20,000 shares | +37% | |
| 28Weak | NAUTbuy Nautilus Biotechnology, Inc. | Anna Mowry CFO and Treasurer | $11k 15,000 shares | +22% | |
| 10Weak | NAUTbuy Nautilus Biotechnology, Inc. | Parag Mallick Chief Scientist | $9,885 13,500 shares | +0% | |
| 31Weak | NAUTsell Nautilus Biotechnology, Inc. | Mary E. Godwin Senior VP, Operations | $135k 47,031 shares | -100% | |
| 30Weak | NAUTsell Nautilus Biotechnology, Inc. | Mary E. Godwin Senior VP, Operations | $100k 35,000 shares | -100% | |
| 39Weak | NAUTbuy Nautilus Biotechnology, Inc. | Sujal M Patel CEO, President, and Secretary | $41k 14,474 shares | +0% | |
| 38Weak | NAUTbuy Nautilus Biotechnology, Inc. | Sujal M Patel CEO, President, and Secretary | $99k 35,526 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.